New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

RSPHvsBMEDETF Comparison

ETF 1
RSPH

Invesco S&P 500® Equal Weight Health Care ETF

This fund is part of
US Health Care
+0.03%
VS
ETF 2
BMED

iShares Health Innovation Active ETF

This fund is part of
Healthcare Technology
-0.67%

Invesco S&P 500® Equal Weight Health Care ETF (RSPH) belongs to the US Health Care segment. iShares Health Innovation Active ETF (BMED) is part of the Healthcare Technology segment. RSPH's top 2 sector exposures are Healthcare and Consumer Non-Cyclicals. In contrast, BMED's top sector exposures are Healthcare and Non-Corporate. RSPH is less expensive with a Total Expense Ratio (TER) of 0.4%, versus 0.77% for BMED. RSPH is up 25.34% year-to-date (YTD) with +$61M in YTD flows. BMED performs worse with 20.72% YTD performance, and +$5M in YTD flows. Run a side-by-side ETF comparison of RSPH and BMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

RSPH vs BMED performance and flow charts

Performance

-2.00.02.04.06.08.0%Sep 30Oct 7Oct 14Oct 21Oct 28

Cumulative Flows

010,000,00020,000,00030,000,00040,000,00050,000,000Sep 30Oct 7Oct 14Oct 21Oct 28

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/30/2026
1M3MYTD1Y3Y5Y
Perf.
RSPH
BMED
+7.26%+5.68%
+13.92%+16.66%
+25.34%+20.72%
+32.12%+28.92%
+60.29%+75.53%
+32.89%+21.83%
Flows
RSPH
BMED
+$45M-
+$104M+$1M
+$61M+$5M
+$57M+$6M
-$224M+$7M
-$206M+$6M
Volatility and drawdown
3M1Y3Y5Y
Volatility
RSPH
BMED
+18.23%+21.69%
+16.84%+18.00%
+15.92%+16.83%
+16.81%+18.17%
Max drawdown
RSPH
BMED
-5.57%-5.85%
-10.87%-14.71%
-16.96%-19.76%
-21.91%-32.14%
Max drawdown duration
RSPH
BMED
55d31d
116d196d
434d237d
817d1479d
Trading data

Create an account to view trading data

Join for free
RSPH
BMED
Last sale
10/30/2026 at 1:30 PM
$39.69
$36.50
Previous close
10/29/2026
$40.14
$36.72
Consolidated volume
10/29/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of October 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

BMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
RSPH
BMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Main metrics
Last update 10/30/2026 at 1:30 PM
Live
Closed
RSPH
BMED
Last price
$39.69
$36.50
1D performance
-1.12%
-0.60%
AuM$982.79 M$14.58 M
E/R0.4%0.77%
Characteristics
RSPH
BMED
Management strategyPassiveActive
ProviderInvescoiShares
BenchmarkS&P 500 Equal Weight Health Care Index-
N° of holdings6053
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateNovember 1, 2006September 29, 2020
ESGNoNo
Exposure

Countries

RSPH
USA
96.84%
Other
3.16%
BMED
USA
86.39%
Other
13.61%

Sectors

RSPH
Healthcare
98.51%
Other
1.49%
BMED
Healthcare
97.84%
Other
2.16%
Advertisement

Diversification

RSPH

Total weight of top 15 holdings out of 15

28.14%
BMED

Total weight of top 15 holdings out of 15

57.51%

Top 15 holdings

Data as of September 30, 2026
RSPH
Moderna, Inc.
2.35%
Illumina, Inc.
2.14%
Revvity, Inc.
1.97%
Agilent Technologies, Inc.
1.96%
Mettler-Toledo International, Inc.
1.94%
Intuitive Surgical, Inc.
1.90%
Thermo Fisher Scientific, Inc.
1.81%
West Pharmaceutical Services, Inc.
1.80%
Danaher Corp.
1.79%
Viatris, Inc.
1.79%
Waters Corp.
1.77%
Biogen, Inc.
1.75%
Veeva Systems, Inc.
1.74%
Amgen, Inc.
1.73%
AbbVie, Inc.
1.71%
BMED
Moderna, Inc.
5.19%
Danaher Corp.
5.19%
Gilead Sciences, Inc.
5.00%
AbbVie, Inc.
4.61%
Thermo Fisher Scientific, Inc.
4.41%
Johnson & Johnson
4.17%
IQVIA Holdings, Inc.
3.75%
Waters Corp.
3.66%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.35%
Mettler-Toledo International, Inc.
3.33%
Merck & Co., Inc.
3.10%
Edwards Lifesciences Corp.
2.96%
Illumina, Inc.
2.70%
Roche Holding AG
2.58%
Frequently asked questions about RSPH and BMED

How have the RSPH and BMED ETFs performed in 2026?

As of October 30, 2026, RSPH is up 25.34% year-to-date (YTD), while BMED has returned 20.72%. That puts RSPH better performer ahead so far this year.

Which ETF is attracting more investor money: RSPH or BMED?

Year-to-date, the RSPH ETF saw +$61M in flows, compared to +$5M for BMED.

Which ETF is more volatile: RSPH or BMED?

Over the past year, RSPH had a volatility of 16.84%, while BMED experienced 18%.

Which ETF is bigger: RSPH or BMED?

As of October 30, 2026, RSPH holds $982.79 M in assets under management (AUM), while BMED manages $14.58 M.

What sectors do the RSPH and BMED ETFs invest in?

RSPH leans toward sectors like Healthcare. Meanwhile, BMED focuses on Healthcare.

What are the top holdings of the RSPH ETF and BMED ETF?

RSPH top holdings include Moderna, Inc., Illumina, Inc. and Revvity, Inc.. BMED holds in its top three: Moderna, Inc., Danaher Corp. and Gilead Sciences, Inc..

Which ETF is more diversified: RSPH or BMED?

RSPH holds 60 securities with 28.14% of its assets in the top 15. BMED has 55 securities and a top 15 weight of 57.51%.

Latest news about RSPH & BMED
Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026